Model Number 72204064 |
Device Problems
Suction Problem (2170); Failure to Cut (2587); Adverse Event Without Identified Device or Use Problem (2993); Appropriate Term/Code Not Available (3191)
|
Patient Problem
Insufficient Information (4580)
|
Event Date 03/30/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
D10 concomitant product/s: 72204064 truclear ultra mini tissue removal devic lot #:5446938.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
According to the reporter, during hysteroscopic resection of 2cm type 1 fibroid, the shaver was being used to resect.Initially the shaver had pierced the fibroid capsule, and a good amount of tissue had been resected.The shaver then appeared to be blunt and would not cut the tissue.It also appeared that the blade did not reach the shaver 'cap' to effectively cut the tissue.The surgeon used the shaver on endometrium to see if the less fibrous tissue would be cut and sucked into the shaver; this was unsuccessful.The blade did not appear to reach the top of the shaver cap to make a cut in the tissue.The fibroid could not be successfully completely removed.Another shaver with the same lot number was opened.An additional shaver was opened, but this too would not cut the fibroid tissue well.The procedure was aborted, fibroid resection was incomplete.A video was attached and showed that the blade was not cutting the tissue.An additional procedure will be scheduled to attempt to resect the remainder of the fibroid that was not resected during the procedure.
|
|
Manufacturer Narrative
|
H3 evaluation summary: medtronic conducted an investigation based upon all information received.The device and a photo were available for evaluation.The evaluation found no potentially contributing factors, and the sample met all related specifications.It was reported that the procedure was aborted due to a device malfunction, the device had no suction and had a cutting issue.The reported issues could not be confirmed.The most likely cause could not be identified because no related problem was detected with the device.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
According to the reporter, during hysteroscopic resection of 2cm type 1 fibroid, the shaver was being used to resect.Initially the shaver had pierced the fibroid capsule, and a good amount of tissue had been resected.The shaver then appeared to be blunt, and would not cut the tissue.It also appeared that the blade did not reach the shaver 'cap' to effectively cut the tissue, the surgeon used the shaver on endometrium to see if the less fibrous tissue would be cut and sucked into the shaver, this was unsuccessful.The blade did not appear to reach the top of the shaver cap to make a cut in the tissue.The fibroid could not be successfully completely removed.Another shaver with the same lot number was opened.An additional shaver was opened, but this too would not cut the fibroid tissue well.The procedure was aborted, fibroid resection was incomplete.A video was attached and showed that the blade was not cutting the tissue.An additional procedure will be scheduled to attempt to resect the remainder of the fibroid that was not resected during the procedure.The patient was anesthetized during the procedure and at the time when the procedure was aborted.
|
|
Search Alerts/Recalls
|
|